Aging & Hair Loss Explained: OS-01’s Science-Backed Approach

OneSkin's approach is rooted in the biology of aging. As we age, senescent cells accumulate in tissues, including the scalp, where they secrete factors that impair the function of neighboring healthy cells and break down the extracellular matrix. In hair, this translates to follicle miniaturization and eventual loss. Karolina's team first validated that a stress hormone (cortisol-like) could induce senescence in cultured hair follicle cells. They then showed that OS-01 treatment reversed the number of senescent cells and stimulated hair shaft elongation in lab models. The clinical trial, conducted independently, demonstrated robust regrowth that outpaced minoxidil. Because the product is drug-free and targets a pathway common to many types of hair loss (cellular senescence and inflammation), it can be layered with other therapies. The twice-daily recommendation comes from the clinical protocol; however, Karolina herself uses once-daily at night due to convenience and sees results, suggesting that prevention dosing can be lighter.

Karolina explained that estrogen is a key hormonal signal for keeping hair in the growth phase, so when it drops during menopause or postpartum, hair transitions to the shedding phase. Progesterone naturally prevents testosterone from converting to dihydrotestosterone (DHT), the androgen that miniaturizes hair follicles. As progesterone declines, more DHT binds follicle receptors and accelerates thinning. While HRT can slow this process, it doesn't necessarily stimulate regrowth. Adding OS-01 provides a complementary mechanism: it targets the senescent cell burden and inflammation that further impair the follicle. This dual approach could be more effective than either alone. She suggested that a strong protocol could be "OS-01 topical + HRT or progesterone."

Karolina explained that OneSkin started by modeling skin aging in the lab, screening hundreds of peptides to find one that could significantly reduce the burden of senescence. They landed on OS-01, a peptide that selectively removes these dysfunctional cells, allowing healthy cells to replicate and function properly. When they turned to hair, they hypothesized that the same biology could be at play. Published mouse studies show that clearing senescent cells systemically leads to fuller, healthier fur, hinting at a direct link between senescence and hair quality. Their own in vitro work confirmed that a stress hormone like cortisol could induce senescence in hair follicle cells, and that OS-01 reversed that accumulation. This positions OS-01 as the first topical hair product designed to treat the underlying aging process in hair follicles, not just the symptoms.

The clinical trial, run by an independent contract research organization (CRO), included two arms: one using the OS-01 formula and one using minoxidil. Both were applied twice daily for six months. The OS-01 group showed a 40% increase in hair density and a 40% increase in hair thickness as measured by the HairMetrix instrument. Karolina expressed genuine surprise at the magnitude of the result, and she plans to publish the full data. This positions OS-01 not just as an alternative but as a potentially superior option, with the added benefit of a novel mechanism that reduces senescent cells and inflammation rather than just boosting nutrient supply.

Karolina detailed that the formulation was designed to complement OS-01. Ficetin adds antioxidant and anti-inflammatory effects, while also possessing some senolytic properties. The prebiotics feed beneficial bacteria, helping to shift the scalp microbiome from a state associated with hair loss and dandruff to one that maintains hair in the growth phase. In their clinical study, they analyzed scalp microbiome samples at baseline and after six months, observing an increase in good bacteria and a decrease in bad bacteria and fungi linked to dandruff. This systems-level approach recognizes that hair loss is not just about the follicle itself but about the entire ecosystem of the scalp, including barrier function, UV damage, and microbial balance.

Karolina shared her personal regret: she wishes she had this product when she was 30, before noticeable thinning, because she could have been proactive. She noted that just as we apply anti-aging products to our face before deep wrinkles appear, we should be nurturing the scalp's ecosystem to prevent the accumulation of senescent cells and inflammation that eventually leads to hair loss. This is a paradigm shift from treating bald spots to maintaining a healthy scalp over decades. She also emphasized the emotional toll of hair loss, particularly for women, and how proactive care could reduce that distress by maintaining density before the loss becomes visible.

The host and guest discussed how women are hit particularly hard because there is an unspoken expectation that they will not go bald. This leads to anxiety, hiding, and costly procedures done in secrecy. Karolina noted that many women cannot access drug-based solutions because those can interfere with hormones, making a drug-free alternative like OS-01 especially valuable. The conversation underscored that hair loss is not just a cosmetic issue but a profound source of psychological stress, and addressing it with a safe, at-home solution could improve quality of life significantly.